Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham… - Cancer discovery, 2014 - AACR
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …
被引用次数：192 相关文章

Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth… - Cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …

[引用][C] Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth… - CANCER …, 2014 - iris.hunimed.eu

Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham… - Cancer …, 2014 - cir.nii.ac.jp
< jats: title> Abstract</jats: title>< jats: p> Death rates from hepatocellular carcinoma (HCC)
are steadily increasing, yet therapeutic options for advanced HCC are limited. We identify a …
[PDF] archive.org

[PDF][PDF] Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham… - 2014 - scholar.archive.org
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …
[HTML] unifr.ch

[HTML][HTML] Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.

E Horwitz, I Stein, M Andreozzi, J Nemeth… - Cancer …, 2014 - folia.unifr.ch
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …
[PDF] academia.edu

[PDF][PDF] Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham… - 2014 - academia.edu
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …
[HTML] sonar.ch

[HTML][HTML] Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.

E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham… - Cancer discovery, 2014 - sonar.ch
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …

Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.

E Horwitz, I Stein, M Andreozzi, J Nemeth… - Cancer …, 2014 - europepmc.org
Death rates from hepatocellular carcinoma (HCC) are steadily increasing, yet therapeutic
options for advanced HCC are limited. We identify a subset of mouse and human HCCs …

Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment

E Horwitz, I Stein, M Andreozzi, J Nemeth, A Shoham… - Cancer, 2014 - hero.epa.gov
UNLABELLED: Death rates from hepatocellular carcinoma (HCC) are steadily increasing,
yet therapeutic options for advanced HCC are limited. We identify a subset of mouse and …